The Congressional Quarterly reports that new information is being sought to clarify whether GlaxoSmithKline had data about suicide risks for its anti-depressant Paxil as early as 1989. In May 2006 it alerted health professionals about the risk compared to placebos.
Seroquel extension sought
In an attempt to maintain high profits on its blockbuster drug Seroquel, AstraZeneca is asking to extend patent protection in the US and the European Union. It is also trying to Teva, a generic giant Teva from court action limiting the patent on its $4.03 billion drug. Market watchers dropped the rating of AstraZeneca, and the price fell on the London exchange.
